Skip to content

BIOMIMETIC THERAPEUTICS, INC.

CIK 0001138400

← back to feed
Revenue (TTM)
$2.02M
+17.1% YoY Q3 Nov 2012
Net Income (TTM)
−$24.25M
+2.2% YoY Q3 Nov 2012
EPS Diluted (TTM)
—
Q3 Nov 2012
Gross Margin
—
Q3 Nov 2012
Operating Margin
-1,204.0%
Q3 Nov 2012
Net Margin
-1,200.2%
Q3 Nov 2012
Free Cash Flow (TTM)
−$30.56M
Q3 Nov 2012
Cash
$15.49M
Q3 Nov 2012
Total Debt
—
Q3 Nov 2012
Shares Outstanding
28.23M sh
Q3 Nov 2012

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings